Skip to main content
SpringerLink
Log in

Dumping syndrome

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

The dumping syndrome consists of early postprandial abdominal and vasomotor symptoms, resulting from osmotic fluid shifts and release of vasoactive neurotransmitters, and late symptoms secondary to reactive hypoglycemia. Effective relief of symptoms of dumping syndrome can be achieved with dietary modifications to minimize ingestion of simple carbohydrates and to exclude fluid intake during ingestion of the solid portion of the meal. More severely affected individuals may respond to agents such as pectin and guar, which increase the viscosity of intraluminal contents, or to drugs such as the alpha-glucosidase inhibitor acarbose, which blunts the rapid absorption of glucose, and the somatostatin analog octreotide, which alters gut transit and impairs release of vasoactive mediators into the bloodstream.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Hotta T, Taniguchi K, Kobayashi Y, et al.: Postoperative evaluation of pylorus-preserving procedures compared with conventional distal gastrectomy for early gastric cancer. Surg Today 2001, 31:774–779.

    Article  PubMed  CAS  Google Scholar 

  2. Bufler P, Ehringhaus C, Koletzko S: Dumping syndrome: a common problem following Nissen fundoplication in young children. Ped Surg Int 2001, 17:351–355.

    Article  CAS  Google Scholar 

  3. Samuk I, Afriat R, Horne T, et al.: Dumping syndrome following Nissen fundoplication, diagnosis and treatment. J Ped Gastroenterol Nutr 1996, 23:235–240.

    Article  CAS  Google Scholar 

  4. Ralphs DN, Thomson JP, Haynes S, et al.: The relationship between the rate of gastric emptying and the dumping syndrome. Br J Surg 1978, 65:637–641.

    Article  PubMed  CAS  Google Scholar 

  5. Eagon JC, Miedema BW, Kelly KA: Postgastrectomy syndromes. Surg Clin North Am 1992, 72:445–465.

    PubMed  CAS  Google Scholar 

  6. MacGregor I, Parent J, Meyer JH: Gastric emptying of liquid meals and pancreatic and biliary secretion after subtotal gastrectomy or truncal vagotomy and pyloroplasty in man. Gastroenterology 1977, 72:195–205.

    PubMed  CAS  Google Scholar 

  7. Gulsrud PO, Taylor IL, Watts HD, et al.: How gastric emptying of carbohydrate affects glucose tolerance and symptoms after truncal vagotomy with pyloroplasty. Gastroenterology 1980, 78:1463–1471.

    PubMed  CAS  Google Scholar 

  8. Machella TE: Mechanism of the post-gastrectomy dumping syndrome. Gastroenterology 1968, 54(suppl):721–722.

    PubMed  Google Scholar 

  9. Kaushik SP, Ralphs DN, Hobsley M, Le Quesne LP: Use of a provocative test for objective assessment of dumping syndrome in patients undergoing surgery for duodenal ulcer. Am J Gastroenterol 1980, 74:251–257.

    PubMed  CAS  Google Scholar 

  10. Bond JH, Levitt MD: Use of breath hydrogen (H2) to quantitate small bowel transit time following partial gastrectomy. J Lab Clin Med 1977, 90:30–36.

    PubMed  CAS  Google Scholar 

  11. Lawaetz O, Blackburn AM, Bloom SR, et al.: Gut hormone profile and gastric emptying in the dumping syndrome. Scand J Gastroenterol 1983, 18:73–80.

    Article  PubMed  CAS  Google Scholar 

  12. Vecht J, Gielkens HA, Frolich M, et al.: Vasoactive substances in early dumping syndrome: effects of dumping provocation with and without octreotide. Eur J Clin Invest 1997, 27:680–684.

    Article  PubMed  CAS  Google Scholar 

  13. Gebhard B, Holst JJ, Biegelmayer C, Miholic J: Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci 2001, 46:1915–1923. This article presents the most recent description of neurohumoral phenomena associated with late dumping syndrome.

    Article  PubMed  CAS  Google Scholar 

  14. Toft-Nielsen M, Madsbad S, Holst JJ: Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycemia. Diabetologia 1998, 41:1180–1186.

    Article  PubMed  CAS  Google Scholar 

  15. Lamers CB, Bijlstra AM, Harris AG: Octreotide, a longacting somatostatin analog, in the management of postoperative dumping syndrome. Dig Dis Sci 1993, 38:359–364.

    Article  PubMed  CAS  Google Scholar 

  16. Van der Kleij FG, Vecht J, Lamers CB: Diagnostic value of dumping provocation in patients after gastric surgery. Scand J Gastroenterol 1996, 31:1162–1166. This article presents the most careful assessment of physiologic changes that occur in association with the dumping syndrome.

    PubMed  Google Scholar 

  17. Leeds AR, Ebeid V, Ralphs DN, et al.: Pectin in the dumping syndrome. Lancet 1981, 1:1075–1078.

    Article  PubMed  CAS  Google Scholar 

  18. McKelvey ST: Gastric incontinence and postvagotomy diarrhea. Br J Surg 1970, 57:741–747.

    Article  PubMed  CAS  Google Scholar 

  19. Meyer JH, Gu YG, Jehn D, Taylor IL: Intragastric vs. intraintestinal viscous polymers and glucose tolerance after liquid meals of glucose. Am J Clin Nutr 1988, 48:260–266.

    PubMed  CAS  Google Scholar 

  20. Rydning A, Berstad A, Berstad T, Hertzenberg L: The effect of guar gum and fiber-enriched wheat bran on gastric emptying of a semisolid meal in healthy subjects. Scand J Gastroenterol 1985, 20:330–334.

    PubMed  CAS  Google Scholar 

  21. Harju E, Larmi TK: Efficacy of guar gum in preventing the dumping syndrome. J Parenteral Enteral Nutr 1983, 7:470–472.

    Article  CAS  Google Scholar 

  22. Imhof A, Schneemann M, Schaffner A, Brandle M: Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose. Swiss Med Weekly 2001, 131:81–81.

    CAS  Google Scholar 

  23. Ozden AG, Hamulu F, Bayraktar F, et al.: Long-term treatment with acarbose for the treatment of reactive hypoglycemia. Eating Weight Dis 1998, 3:136–140.

    Google Scholar 

  24. Hasegawa T, Yoneda M, Nakamura K, et al.: Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome. J Gastroenterol Hepatol 1998, 13:1201–1206. This study presents data that support the use of acarbose in late dumping syndrome.

    Article  PubMed  CAS  Google Scholar 

  25. Long RG, Adrian TE, Bloom SR: Somatostatin and the dumping syndrome. Br Med J 1985, 290:886–888.

    Article  CAS  Google Scholar 

  26. Reasbeck PG, Van Rij AM: The effect of somatostatin on dumping after gastric surgery: a preliminary report. Surgery 1986, 99:462–468.

    PubMed  CAS  Google Scholar 

  27. Tulassay Z, Tulassay T, Tamas G: Benefits of somatostatin in dumping syndrome. Surgery 1988, 103:130–131.

    PubMed  CAS  Google Scholar 

  28. Hopman WP, Wolberink RG, Lamers CB, Van Tongeren JH: Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995. Ann Surg 1988, 207:155–159.

    Article  PubMed  CAS  Google Scholar 

  29. Primrose JN, Johnston D: Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy. Br J Surg 1989, 76:140–144.

    Article  PubMed  CAS  Google Scholar 

  30. Gray JL, Debas HT, Mulvahill SJ: Control of dumping symptoms by somatostatin analogue in patients after gastric surgery. Arch Surg 1991, 126:1231–1235.

    PubMed  CAS  Google Scholar 

  31. Geer RJ, Richards WO, O’Dorisio TM, et al.: Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 1990, 212:678–687.

    Article  PubMed  CAS  Google Scholar 

  32. Tulassay Z, Tulassay T, Gupta R, et al.: Long-acting somatostatin analogue in dumping syndrome. Br J Surg 1989, 76:1294–1295.

    Article  PubMed  CAS  Google Scholar 

  33. Li-Ling J, Irving M: Therapeutic value of octreotide for patients with severe dumping syndrome—a review of randomised controlled trials. Postgrad Med J 2001, 77:441–442. This article summarizes the results of seven studies comparing octreotide with placebo in patients with dumping syndrome.

    Article  PubMed  CAS  Google Scholar 

  34. Parr N, Grime S, Jenkins SA, et al.: Somatostatin analogue (SMS 201-995) inhibits early rapid gastric emptying after truncal vagotomy and drainage [abstract]. Gut 1986, 27:A1272.

    Google Scholar 

  35. Hasler WL, Soudah HC, Owyang C: Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome. J Pharmacol Exp Ther 1996, 277:1359–1365. This study demonstrates that octreotide blunts many of the exaggerated responses associated with dumping syndrome, providing physiologic rationale for its therapeutic use.

    PubMed  CAS  Google Scholar 

  36. Fuessl HS, Carolan G, Williams G, et al.: Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man. Digestion 1987, 36:101–107.

    PubMed  CAS  Google Scholar 

  37. Tulassay Z, Tulassay T, Gupta R, Cierny G: Long-acting analogue of somatostatin—SMS 201-995—is highly effective in the prevention of clinical symptoms related to the dumping syndrome [letter]. Ann Surg 1989, 210:250–252.

    PubMed  CAS  Google Scholar 

  38. Tulassay Z, Tulassay T, Gupta R, Tamas G: The effect of somatostatin in dumping syndrome after gastric surgery. Acta Gastroenterol Belg 1993, 56:219–222.

    PubMed  CAS  Google Scholar 

  39. Vecht J, Lamers CB, Masclee AA: Long-term results of octreotide-therapy in severe dumping syndrome. Clin Endocrinol 1999, 51:619–624. This is the largest series of patients followed long-term on octreotide therapy for dumping syndrome.

    Article  CAS  Google Scholar 

  40. Lamers CB, Bijlstra AM, Harris AG: Octreotide, a longacting somatostatin analog, in the management of postoperative dumping syndrome. An update. Dig Dis Sci 1993, 38:359–364.

    Article  PubMed  CAS  Google Scholar 

  41. Morii Y, Arita T, Shimoda K, et al.: Jejunal interposition to prevent postgastrectomy syndromes. Br J Surg 2000, 87:1576–1579.

    Article  PubMed  CAS  Google Scholar 

  42. Sawyers JL, Herrington JL: Superiority of antiperistaltic jejunal segments in management of severe dumping syndrome. Ann Surg 1973, 178:311–321.

    Article  PubMed  CAS  Google Scholar 

  43. Mackie CR, Hall AW, Clark J, et al.: The effect of isoperistaltic jejunal interposition upon gastric emptying. Surg Gyn Obstet 1981, 143:813–819.

    Google Scholar 

  44. Richards WO, Golzarian J, Wasudev N, Sawyers JL: Reverse phasic contractions are present in antiperistaltic jejunal limbs up to twenty-one years postoperatively. J Am Coll Surg 1994, 178:557–563.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, University of Michigan Medical Center, 3912 Taubman Center, Box 0362, 48109, Ann Arbor, MI, USA

    William L. Hasler MD

Authors
  1. William L. Hasler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hasler, W.L. Dumping syndrome. Curr Treat Options Gastro 5, 139–145 (2002). https://doi.org/10.1007/s11938-002-0061-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-002-0061-7

Keywords

Search

Navigation